Patent · US Active

Polymorphs and solid forms of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide, and methods of production

US11028100B2 · kind B2 · utility

2Cited by

9References

25Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Paroma Chakravarty · San Francisco, US
Chong Han · Foster City, US
Sean M. Kelly · Williamsville, US
Karthik Nagapudi · South San Francisco, US
Scott Savage · Redwood City, US

Key dates

Filing date	May 15, 2020
Grant date	Jun 8, 2021
Priority date	—
Expiry date	May 15, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to crystalline polymorph forms of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino)propanamide (GDC-0077), having the structure, Formula I:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.